These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 15760548

  • 1. [Preoperation risk factor analysis in orthotopic liver transplantation with pre-transplant artificial liver support therapy].
    Yuan JZ, Ye QF, Ming YZ, Hang ZF, Zhao LL, Zhao XY, Wang MM, Zhang MZ, Wen ZX, Zhu SH, Wu K.
    Zhonghua Gan Zang Bing Za Zhi; 2005 Mar; 13(3):175-8. PubMed ID: 15760548
    [Abstract] [Full Text] [Related]

  • 2. Preoperative risk factor analysis in orthotopic liver transplantation with pretransplant artificial liver support therapy.
    Yuan JZ, Ye QF, Zhao LL, Ming YZ, Sun H, Zhu SH, Huang ZF, Wang MM.
    World J Gastroenterol; 2006 Aug 21; 12(31):5055-9. PubMed ID: 16937506
    [Abstract] [Full Text] [Related]

  • 3. Predictive criteria for the outcome of patients with acute liver failure treated with the albumin dialysis molecular adsorbent recirculating system.
    Novelli G, Rossi M, Ferretti G, Pugliese F, Ruberto F, Lai Q, Novelli S, Piemonte V, Turchetti L, Morabito V, Annesini MC, Berloco PB.
    Ther Apher Dial; 2009 Oct 21; 13(5):404-12. PubMed ID: 19788457
    [Abstract] [Full Text] [Related]

  • 4. Pediatric acute liver failure with molecular adsorbent recirculating system treatment.
    Novelli G, Rossi M, Morabito V, Pugliese F, Ruberto F, Perrella SM, Novelli S, Spoletini G, Ferretti G, Mennini G, Berloco PB.
    Transplant Proc; 2008 Oct 21; 40(6):1921-4. PubMed ID: 18675090
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs.
    Gaspari R, Cavaliere F, Sollazzi L, Perilli V, Melchionda I, Agnes S, Gasbarrini A, Avolio AW.
    Transplant Proc; 2009 Oct 21; 41(1):253-8. PubMed ID: 19249528
    [Abstract] [Full Text] [Related]

  • 7. Molecular adsorbent recirculating system in liver transplantation: Safety and efficacy.
    Gaspari R, Avolio AW, Zileri Dal Verme L, Agnes S, Proietti R, Castagneto M, Gasbarrini A.
    Transplant Proc; 2006 Dec 21; 38(10):3544-51. PubMed ID: 17175327
    [Abstract] [Full Text] [Related]

  • 8. [Early risk factors of acute lung injury following orthotopic liver transplantation].
    Li SR, Shen N, Hei ZQ.
    Zhonghua Yi Xue Za Zhi; 2008 Nov 25; 88(43):3049-52. PubMed ID: 19192404
    [Abstract] [Full Text] [Related]

  • 9. Early liver retransplantation versus late liver retransplantation: analysis of a single-center experience.
    Chen GH, Fu BS, Yang Y, Cai CJ, Lu MQ, Li H, Wang GS, Yi SH, Xu C, Zhang JF, Zhang T, Wang GY.
    Chin Med J (Engl); 2008 Oct 20; 121(20):1992-6. PubMed ID: 19080262
    [Abstract] [Full Text] [Related]

  • 10. Risk stratification of adult patients undergoing orthotopic liver transplantation for fulminant hepatic failure.
    Barshes NR, Lee TC, Balkrishnan R, Karpen SJ, Carter BA, Goss JA.
    Transplantation; 2006 Jan 27; 81(2):195-201. PubMed ID: 16436962
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Postreperfusion syndrome during liver transplantation for cirrhosis: outcome and predictors.
    Paugam-Burtz C, Kavafyan J, Merckx P, Dahmani S, Sommacale D, Ramsay M, Belghiti J, Mantz J.
    Liver Transpl; 2009 May 27; 15(5):522-9. PubMed ID: 19399736
    [Abstract] [Full Text] [Related]

  • 13. [The first clinical experience with orthotopic transplantation of the liver].
    Shumakov VI, Moĭsiuk IaG, Kozlov IA, Tarabarko NV, Petrova GN, Itkin GP, Matveev IuG, Arzumanov VS, Nikolaenko EM, Gvozdev SV.
    Khirurgiia (Mosk); 1991 Jan 27; (1):98-106. PubMed ID: 2041326
    [Abstract] [Full Text] [Related]

  • 14. Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: influence of emergent versus elective procedures on patient survival and tumor recurrence rate.
    Stockland AH, Walser EM, Paz-Fumagalli R, McKinney JM, May GR.
    Cardiovasc Intervent Radiol; 2007 Jan 27; 30(5):888-93. PubMed ID: 17619218
    [Abstract] [Full Text] [Related]

  • 15. Liver transplantation in cirrhotic patients with diabetes mellitus: midterm results, survival, and adverse events.
    Blanco JJ, Herrero JI, Quiroga J, Sangro B, Gómez-Manero N, Pardo F, Cienfuegos JA, Prieto J.
    Liver Transpl; 2001 Mar 27; 7(3):226-33. PubMed ID: 11244164
    [Abstract] [Full Text] [Related]

  • 16. Risk factors for fatal recurrence of hepatocellular carcinoma and their role in selecting candidates for liver transplantation.
    Zou WL, Zang YJ, Chen XG, Shen ZY.
    Hepatobiliary Pancreat Dis Int; 2008 Apr 27; 7(2):145-51. PubMed ID: 18397848
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Liver transplantation for patients with hepatocellular carcinoma at the Liver Cancer Institute of Fudan University, China.
    Zhou J, Fan J, Wu ZQ, Qiu SJ, Huang XW, Yu Y, Wang Z, Sun J, Xiao YS, He YF, Yang GH, Song K, Yuan Z, Wang YQ, Tang ZY.
    Chin Med J (Engl); 2005 Apr 20; 118(8):654-9. PubMed ID: 15899120
    [Abstract] [Full Text] [Related]

  • 19. Results of resection and transplantation for hepatocellular carcinoma in cirrhosis and noncirrhosis.
    Rayya F, Harms J, Bartels M, Uhlmann D, Hauss J, Fangmann J.
    Transplant Proc; 2008 May 20; 40(4):933-5. PubMed ID: 18555082
    [Abstract] [Full Text] [Related]

  • 20. Hepatocellular carcinoma in children and effect of living-donor liver transplantation on outcome.
    Arikan C, Kilic M, Nart D, Ozgenc F, Ozkan T, Tokat Y, Yagci RV, Aydogdu S.
    Pediatr Transplant; 2006 Feb 20; 10(1):42-7. PubMed ID: 16499586
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.